Boxer Capital, LLC Bio Atla, Inc. Transaction History
Boxer Capital, LLC
- $0
- Q4 2024
Shares
1 transactions
Others Institutions Holding BCAB
# of Institutions
69Shares Held
25.6MCall Options Held
30.5KPut Options Held
46.7K-
Anson Funds Management LP Dallas, TX4.6MShares$2.12 Million0.35% of portfolio
-
Acorn Capital Advisors, LLC New York, NY4.03MShares$1.85 Million1.29% of portfolio
-
Highbridge Capital Management LLC New York, NY2.51MShares$1.15 Million0.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$842,9380.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.37MShares$632,0740.06% of portfolio
About BioAtla, Inc.
- Ticker BCAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,304,100
- Market Cap $16.7M
- Description
- BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...